Source:http://linkedlifedata.com/resource/pubmed/id/11294496
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-4-10
|
pubmed:abstractText |
We have studied the effect of several doses of GLP-1, compared to that of insulin and glucagons, on lipogenesis, lipolysis and cAMP cellular content, in human adipocytes isolated from normal subjects. In human adipocytes, GLP-1 exerts a dual action, depending upon the dose, on lipid metabolism, being lipogenic at low concentrations of the peptide (ED50, 10(-12) M), and lipolytic only at doses 10-100 times higher (ED50, 10(-10) M); both effects are time- and GLP-1 concentration-dependent. The GLP-1 lipogenic effect is equal in magnitude to that of equimolar amounts of insulin; both hormones apparently act synergically, and their respective action is abolished by glucagon. The lipolytic effect of GLP-1 is comparable to that of glucagon, apparently additive to it, and the stimulated value induced by either one is neutralized by the presence of insulin. In the absence of IBMX, GLP-1, at 10(-13) and 10(-12) M, only lipogenic doses, does not modify the cellular content of cAMP, while from 10(-11) M to 10(-9) M, also lipolytic concentrations, it has an increasing effect; in the presence of IBMX, GLP-1 at already 10(-12) M increased the cellular cAMP content. In human adipocytes, GLP-1 shows glucagon- and also insulin-like effects on lipid metabolism, suggesting the possibility of GLP-1 activating two distinct receptors, one of them similar or equal to the pancreatic one, accounting cAMP as a second messenger only for the lipolytic action of the peptide.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-3-isobutylxanthine,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon,
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon-Like Peptide 1,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Precursors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0018-5043
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
73-7
|
pubmed:dateRevised |
2009-2-19
|
pubmed:meshHeading |
pubmed-meshheading:11294496-1-Methyl-3-isobutylxanthine,
pubmed-meshheading:11294496-Adipocytes,
pubmed-meshheading:11294496-Cyclic AMP,
pubmed-meshheading:11294496-Dose-Response Relationship, Drug,
pubmed-meshheading:11294496-Female,
pubmed-meshheading:11294496-Glucagon,
pubmed-meshheading:11294496-Glucagon-Like Peptide 1,
pubmed-meshheading:11294496-Humans,
pubmed-meshheading:11294496-Lipid Metabolism,
pubmed-meshheading:11294496-Lipids,
pubmed-meshheading:11294496-Lipolysis,
pubmed-meshheading:11294496-Male,
pubmed-meshheading:11294496-Middle Aged,
pubmed-meshheading:11294496-Peptide Fragments,
pubmed-meshheading:11294496-Protein Precursors
|
pubmed:year |
2001
|
pubmed:articleTitle |
Effect of GLP-1 on lipid metabolism in human adipocytes.
|
pubmed:affiliation |
Department of Metabolism, Nutrition and Hormones, Fundación Jiménez Díaz, Madrid, Spain. mlvillanueva@fjd.es
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|